Disease, Cognition and Ageing (DCA) is a pioneering research program within the UMCG-research institute Health in Context. DCA is an acronym for Disease, Cognition, and Ageing.

Recognition of Cognitive Disturbances

Researchers within DCA investigate prevalence of cognitive problems in neurological and chronic diseases. Understanding how early identification of cognitive impairments impacts disease management and prognosis is a key focus area.

Effects of Diseases and Disorders on Cognitive Functions

From exploring cognitive reserve after traumatic brain injury (TBI),stroke (SAB/CVA) and other neurological disorders to understanding cognitive disturbances in somatic disorders such as chronic kidney disease or cardiovascular diseases, DCA researchers examine the impact of diseases and disorders on cognitive functions. Additionally, they investigate cognitive decline following delirium and the decline in social cognition in neurological disorders and dementia.

Effects of Treatment on Cognition

DCA researchers delve into the effects of various medical treatments on cognitive domains, including chemotherapy, transplantation, dialysis, radiotherapy, and surgery. Our research aims to elucidate cognitive decline or preservation of cognition post-treatment and optimize patient care strategies and decision making.


How our research benefits to society

The multidisciplinary approach of DCA within the Health in Context Research Institute holds great potential for advancing our understanding of disease-related cognitive decline and optimizing strategies for healthy aging and appropriate care.

Major DCA Research Themes are:

  • Cognitive Impairment and effect of treatment in Somatic Diseases
  • Neurological Disorders and Age-Related Cognitive Decline
  • Social cognitive impairment in chronic conditions
  • Proactive Health Strategies for Aging Populations
  • Integrative Approaches to Disease Management in Aging